Citation Impact
Citing Papers
Activity-Dependent Internalization of Smoothened Mediated by ß-Arrestin 2 and GRK2
2004 StandoutScienceNobel
Targeting of Diacylglycerol Degradation to M1 Muscarinic Receptors by ß-Arrestins
2007 StandoutScienceNobel
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
2007 StandoutScienceNobel
Dishevelled 2 Recruits ß-Arrestin 2 to Mediate Wnt5A-Stimulated Endocytosis of Frizzled 4
2003 StandoutScienceNobel
Functional specialization of β-arrestin interactions revealed by proteomic analysis
2007 StandoutNobel
Spinophilin Blocks Arrestin Actions in Vitro and in Vivo at G Protein-Coupled Receptors
2004 StandoutScienceNobel
Keeping G Proteins at Bay: A Complex Between G Protein-Coupled Receptor Kinase 2 and Gßγ
2003 StandoutScienceNobel
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Targeting of Cyclic AMP Degradation to β 2 -Adrenergic Receptors by β-Arrestins
2002 StandoutScienceNobel
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
A novel mouse model of lipotoxic cardiomyopathy
2001
Classical and new roles of β-arrestins in the regulation of G-PROTEIN-COUPLED receptors
2001 StandoutNobel
Fatty Acid Utilization in the Hypertrophied and Failing Heart: Molecular Regulatory Mechanisms
1999
β-Adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic Gsα mouse
1999
Remodelling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin
2000
Altered Expression of Proteins of Metabolic Regulation during Remodeling of the Left Ventricle after Myocardial Infarction
2000
Genetic Ablation and Restoration of the Olfactory Topographic Map
2000 StandoutNobel
A transgenic rabbit model for human hypertrophic cardiomyopathy
1999
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy
2002
Roles of PPARs on regulating myocardial energy and lipid homeostasis
2007
Regulation of G Protein-Coupled Receptor Kinases and Arrestins During Receptor Desensitization
2003 StandoutNobel
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
2011 StandoutNatureNobel
Regulation of β-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2
2007 StandoutNobel
Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation
2004
A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy.
1998
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
2008 StandoutNobel
Deactivation of peroxisome proliferator–activated receptor-α during cardiac hypertrophic growth
2000
Modification of left ventricular hypertrophy by chronic etomoxir treatment
1999
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
2005 StandoutNobel
Importance of quantitative genetic variations in the etiology of hypertension
2000 StandoutNobel
Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway
2006
Hypertrophic Cardiomyopathy
2002 Standout
Expanding roles for β-arrestins as scaffolds and adapters in GPCR signaling and trafficking
2001 StandoutNobel
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart.
1996
The role of cytoskeletal proteins in cardiomyopathies
1998
Seven-transmembrane receptors
2002 StandoutNobel
The Use of Partial Fatty Acid Oxidation Inhibitors for Metabolic Therapy of Angina Pectoris and Heart Failure
2002
Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development
2002
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
2007 Standout
Crystal Structure of β-Arrestin at 1.9 Å
2001
β-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking
2001 StandoutNobel
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
2012 StandoutNobel
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
1999 StandoutScienceNobel
β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα
2004 StandoutNobel
Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice
2002
Increased Cardiac Angiotensin II Levels Induce Right and Left Ventricular Hypertrophy in Normotensive Mice
2000
Fatty Acid Utilization in the Hypertrophied and Failing Heart: Molecular Regulatory Mechanisms
1999
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Altered CXCR2 Signaling in β-Arrestin-2-Deficient Mouse Models
2005
Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2
2003 StandoutNobel
Defective lymphocyte chemotaxis in β-arrestin2- and GRK6-deficient mice
2002 StandoutNobel
Ketone bodies disturb fatty acid handling in isolated cardiomyocytes derived from control and diabetic rats
2003
Low Carbohydrate/High-Fat Diet Attenuates Cardiac Hypertrophy, Remodeling, and Altered Gene Expression in Hypertension
2006
Physiological Roles of G Protein–Coupled Receptor Kinases and Arrestins
2007
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
2000 StandoutNatureNobel
β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes
2006 StandoutNobel
β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7
2009 StandoutNobel
Transgenic Gαq overexpression induces cardiac contractile failure in mice
1997
The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals
2002 StandoutNobel
β-Arrestins and Cell Signaling
2007 StandoutNobel
Cellular and functional defects in a mouse model of heart failure
2000
Different G protein-coupled receptor kinases govern G protein and β-arrestin-mediated signaling of V2 vasopressin receptor
2005 StandoutNobel
beta -Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking
2001
Smoothened Signaling in Vertebrates Is Facilitated by a G Protein-coupled Receptor Kinase
2008
Familial Hypertrophic Cardiomyopathy
1998
Hypertrophic Cardiomyopathy
2001
Functional antagonism of different G protein-coupled receptor kinases for β-arrestin-mediated angiotensin II receptor signaling
2005 StandoutNobel
A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders
1999
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Multifaceted roles of β-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling
2003 StandoutNobel
Conditional lineage ablation to model human diseases
1998
Fatty Acid Oxidation Enzyme Gene Expression Is Downregulated in the Failing Heart
1996
Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene
2001
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands
2009 StandoutNobel
The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex
2009 StandoutNobel
Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice
2002
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
2001 StandoutScienceNobel
β-Arrestins Regulate Atherosclerosis and Neointimal Hyperplasia by Controlling Smooth Muscle Cell Proliferation and Migration
2008 StandoutNobel
Glycan Imaging in Intact Rat Hearts and Glycoproteomic Analysis Reveal the Upregulation of Sialylation during Cardiac Hypertrophy
2014
kurtz, a Novel Nonvisual Arrestin, Is an Essential Neural Gene in Drosophila
2000
Creatine and Creatinine Metabolism
2000 Standout
ß-Arrestin 2 Mediates Endocytosis of Type III TGF-ß Receptor and Down-Regulation of Its Signaling
2003 StandoutScienceNobel
Transduction of Receptor Signals by ß-Arrestins
2005 StandoutScienceNobel
Chemical Glycoproteomics
2016 StandoutNobel
Works of Michael E. Christe being referenced
Role of MgADP in the development of diastolic dysfunction in the intact beating rat heart.
1997
Altered Glucose and Fatty Acid Oxidation in Hearts of the Spontaneously Hypertensive Rat
1994
Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.
1998
Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy mice.
1997
The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an α-cardiac myosin heavy chain missense mutation
1999
Cardiac Glucose and Fatty Acid Oxidation in the Streptozotocin-Induced Diabetic Spontaneously Hypertensive Rat
1995
A Mouse Model of Familial Hypertrophic Cardiomyopathy
1996 Science
β-Arrestin1 Knockout Mice Appear Normal but Demonstrate Altered Cardiac Responses to β-Adrenergic Stimulation
1997